Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  • Francesco d'Amore
  • Thomas Relander
  • Grete F Lauritzsen
  • Esa Jantunen
  • Hans Hagberg
  • Harald Anderson
  • Harald Holte
  • Anders Österborg
  • Mats Merup
  • Peter Brown
  • Outi Kuittinen
  • Martin Erlanson
  • Bjørn Østenstad
  • Unn-Merete Fagerli
  • Ole Vestergaard Gadeberg
  • Christer Sundström
  • Jan Delabie
  • Elisabeth Ralfkiaer
  • Martine Vornanen
  • Helle Toldbod
View graph of relations
Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To evaluate the efficacy of a dose-dense approach consolidated by up-front high-dose chemotherapy (HDT) and autologous stem-cell transplantation (ASCT) in PTCL, the Nordic Lymphoma Group (NLG) conducted a large prospective phase II study in untreated systemic PTCL. This is the final report, with a 5-year median follow-up, of the NLG-T-01 study.
Original languageEnglish
JournalJournal of Clinical Oncology
Volume30
Issue number25
Pages (from-to)3093-9
Number of pages7
ISSN0732-183X
DOIs
Publication statusPublished - 2012

    Research areas

  • Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Cyclophosphamide, Disease Progression, Disease-Free Survival, Doxorubicin, Etoposide, Europe, Female, Humans, Kaplan-Meier Estimate, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Multivariate Analysis, Neoadjuvant Therapy, Prednisone, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Stem Cell Transplantation, Time Factors, Transplantation, Autologous, Treatment Outcome, Vincristine, Young Adult

ID: 36554097